Freshleaf Analytics News

Australian government proposes CBD be made available for retail sale Today the Therapeutic Goods Administration released the Department of Health-initiated proposal to make low-dose CBD

Australian Senate Committee tables recommendations from inquiry into barriers to medical cannabis The Community Affairs and References Committee tabled their report today (25/3/20) on the

What does a global recession mean for the cannabis industry? COVID-19 is wreaking havoc on the global economy. And there are genuine concerns about a

Medical cannabis quality crack-down   The Therapeutic Goods Administration (TGA) has announced it will be ramping up the number of quality audits it conducts on

We attended the ODC’s consultation session on proposed medical cannabis license changes so you didn’t have to The Office of Drug Control (ODC) held consultation

[gdlr_core_button button-text=”See the Webinar” button-link=”https://attendee.gotowebinar.com/recording/5834975572267909131″ button-link-target=”_blank” margin-right=”20px” ]

The TGA is re-examining the clinical evidence for medical cannabis – including over-the-counter CBD This is the third article in our series about the Department

Department of Health releases new medical cannabis patient access info The TGA tends to avoid speaking about prescriptions because they have no direct oversight regarding

Department of Health provides new commercial insights to Senate Inquiry The Senate Inquiry into the current barriers to patient access to medicinal cannabis in Australia

FreshLeaf’s top ten 2020 trends for Australia’s medical cannabis industry You don’t need a crystal ball to know that 2020 is going to be a

New Zealand finalises medical cannabis regulations Today the Misuse of Drugs (Medicinal Cannabis) Regulations 2019 were published, setting out the regulations for a New Zealand